Related Experiment Video
Updated: Nov 16, 2025

09:36
Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases
Published on: June 28, 2019
10.3K
Teaching Video NeuroImage: Improvement in Motor Development After Start of Levodopa in Tyrosine Hydroxylase
Etienne Janssen1, Mayke Oosterloo2, Estela Rubio-Gozalbo2
1From the Departments of Pediatrics (E.J., E.R.-G.), Neurology (M.O., J.N.), and Clinical Genetics (E.R.-G.), Maastricht University Medical Center; and Department of Genetics (K.v.G.), University Medical Center Utrecht, the Netherlands. etienne.janssen@mumc.nl.
Neurology
|February 25, 2021
Abstract
No abstract available in PubMed .
Related Concept Videos
Parkinson's Disease: Treatment
743
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
743
Parkinson's Disease: Overview
1.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.2K

